309 related articles for article (PubMed ID: 9353829)
1. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
5. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
6. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
8. [Flowcytometry DNA analysis of oral and maxillofacial non-Hodgkin's lymphoma].
Ma L; He Z; Wu L; Cai Y; Huang H; Lei S
Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Jun; 20(3):193-6. PubMed ID: 12600064
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of cell cycle in acute leukemias and non-Hodgkin's lymphomas in children].
Pituch-Noworolska A; Gawlicka M
Acta Haematol Pol; 1993; 24(4):365-71. PubMed ID: 8303983
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
[TBL] [Abstract][Full Text] [Related]
13. DNA content of T-cell lymphomas. A flow-cytometric analysis.
Egerter DA; Said JW; Epling S; Lee S
Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
[TBL] [Abstract][Full Text] [Related]
14. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
Smaaland R; Lote K; Sothern RB; Laerum OD
Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
[TBL] [Abstract][Full Text] [Related]
15. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases.
Servitje O; Martí RM; Estrach T; Palou J; Gallardo F; Limón A; Romagosa V
Eur J Dermatol; 2000; 10(1):43-6. PubMed ID: 10694298
[TBL] [Abstract][Full Text] [Related]
17. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas.
Czader M; Mazur J; Pettersson M; Liliemark J; Strömberg M; Christensson B; Tribukait B; Auer G; Ost A; Porwit A
Cancer; 1996 Mar; 77(6):1180-8. PubMed ID: 8635141
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma discrimination by computerized triple matrix analysis of list mode data from three-color flow cytometric immunophenotypes of bone marrow aspirates.
Bartsch R; Arland M; Lange S; Kahl C; Valet G; Höffkes HG
Cytometry; 2000 Sep; 41(1):9-18. PubMed ID: 10942891
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]